Abstract : An antimicrobial susceptibility test was conducted to compare the resistance rates among Campylobacter spp. isolates from dogs (n = 50) raised under diverse conditions and humans (n = 50). More than 60% of Campylobacter (C.) jejuni from dogs and humans showed resistance to nalidixic acid, enrofloxacin and ciprofloxacin. C. jejuni isolates from humans showed higher resistance to tetracycline (83.3%) and ampicillin (91.3%) than those from dogs. None of the C. jejuni or Campylobacter coli isolates from humans or dogs were resistant to erythromycin. Overall, 85% of Campylobacter spp. isolates showed a multidrug resistant phenotype. Nucleotide sequencing analysis of the gryA gene showed that 100% of NA R /CIP R C. jejuni isolates from dogs and humans had the Thr-86 t h -Ile mutation, which is associated with fluoroquinolone resistance. flaA PCR restriction fragment length polymorphism (RFLP) typing to differentiate the isolates below the species level revealed 12 different clusters out of 73 strains. The human isolates belonged to eight different RFLP clusters, while five clusters contained dog and human isolates.
Introduction
Campylobacter spp. are one of the leading causes of acute bacterial diarrhea worldwide. Infection with Campylobacter (C.) jejuni or Campylobacter (C.) coli is characterized by the sudden onset of fever, abdominal pains, and diarrhea with blood and leukocytes [4, 20] . Occasionally, postinfectious sequale following C. jejuni infection includes reactive arthritis and Guillian-barre syndrome [8] . There are many possible sources of infection with C. jejuni and C. coli, as they constitute the normal intestinal flora in a wide range of birds and mammals [4, 31] . Large-scale outbreaks of human campylobacteriosis are rare and usually linked to the consumption of contaminated water or raw milk. Sporadic cases of campylobacteriosis are frequently associated with the consumption of undercooked chicken, thus contaminated poultry meat is a major risk factor contributing to human infections [14, 17] .
The household dog has previously been identified as a risk factor for human campylobacteriosis [1, 3, 29] . Most of dogs carrying the bacteria are asymptomatic, serving as reservoirs capable of shedding Campylobacter spp. in the feces. The fecal shedding of bacteria may increase the chance of infection in other animals by contaminating the environment [12, 23] .
Most human infection with C. jejuni and C. coli is selflimiting and antimicrobials are usually not recommended for treatment. Occasionally, treatment with erythromycin or fluoroquinolone is used for individuals with invasive or severe infection [23] . Recently, resistance to fluoroquinolone is increasing worldwide. The increase of antimicrobial resistance in Campylobacter spp. is recognized as a major public health concern, and fluoroquinolone resistance is the most common among the human-origin isolates of both C. jejuni and C. coli [22, 27] .
The primary target of the fluoroquinolones to C. jejuni has been shown to be DNA gyrase, a type II topoisomerase that is an essential enzyme for DNA replication [9, 26] . DNA gyrase is composed of two A and B subunits encoded by the gyrA and gyrB genes, respectively. A point mutation at the codon 86 (ACA to ATA) in the quinolone resistance-deter-*Corresponding author Tel: +82-55-772-2345, Fax: +82-55-772-2808/2349 E-mail: yho157@gnu.ac.kr mining region (QRDR) of the gyrA gene, leading to substitution of isoleucine (Ile) for threonine (Thr), is the most common cause of fluoroquinolone resistance among C. jejuni isolates [25, 28] . There are anecdotal reports of mutations leading to additional amino acid changes as well as silent nucleotide mutations [19, 21] .
There are several methods available for epidemiological strain typing to determine the source of Campylobacter spp. infection. These methods include PCR restriction fragment length polymorphism (PCR-RFLP) analysis based on the flagellin gene (flaA typing), pulsed-field gel electrophoresis (PFGE), and amplified fragment length polymorphism (AFLP) analysis. Assessment of the strain typing methods based on the genotypes of Campylobacter spp. has been described in a recent review paper [30] . The RFLP method is simple and reasonable, and has sufficient discriminatory power useful for the typing of C. jejuni and C. coli [17] .
Accordingly, the aim of this study was to investigate the prevalence of antimicrobial resistant Campylobacter spp. isolated from dogs and humans and to confirm the relationship between fluoroquinolone-resistance and the gyrA mutation by DNA sequencing of the gyrA gene. In order to investigate epidemiological relatedness of Campylobacter spp. isolated from dogs and humans, a PCR-RFLP method for the flaA typing was also employed [19] . 
Materials and Methods

Bacterial strains and growth condition
Antimicrobial susceptibility test
Antimicrobial susceptibility test was performed by agar dilution method with Mueller-Hinton agar supplement with 5% sheep blood, according to the protocols of Clinical and Laboratory Standards Institute (CLSI) [5] . C. jejuni ATCC 33560 and C. coli ATCC 33559 were used as the quality control organisms for the test. Erythromycin (EM 0.03-64 µg/ mL), tetracycline (TC 0.125-512 µg/mL), nalidixic acid (NA 0.25-512 µg/mL), enrofloxacin (ENO 0.03-64 µg/mL), ciprofloxacin (CIP 0.03-128 µg/mL), gentamicin (GM 0.25-512 µg/ mL) and ampicillin (AM 0.25-512 µg/mL) were added to the agar plate by a ten-fold serial dilution. Bacterial turbidity for plating was adjusted by using a 0.5 Macfarland standard, according to the guideline of CLSI [5] .
Minimal inhibitory concentration (MIC) values for resistance criteria were set towards EM (≥ 32 µg/mL), TC (≥ 16 µg/mL), NA (≥ 64 µg/mL), ENO (≥ 2 µg/mL), CIP (≥ 4 µg/ mL), GM (≥ 8 µg/mL), and AM (≥ 32 µg/mL) in accordance with a previous report [2] . Multidrug resistance (MDR) was defined as the case exhibiting resistance to two or more antimicrobials at the same time. The bacterial inoculum was applied to the plate with multipoint inoculator. Then, the agar plates were incubated at 42 
DNA extraction
Genomic DNA was extracted from the fresh culture by using QIA amp DNA Mini kit (Qiagen, Germany) according to the recommendations of the manufacturer. The DNA concentration was measured spectrophotometrically at A . DNA sequencing of the gyrA gene DNA sequencing of the gyrA genes was performed to confirm the relationship between the fluoroquinolone resistance and the gyrA mutation. The DNA amplification was carried out in a thermal cycler using a forward primer (5'-GCTATG-CAAATGATGAGGC-3') and a reverse primer (5'-CAG-TATAACGCATCGCAGCGG-3'). The reaction mixture contained 5 µL of PCR buffer [10 mM Tris-HCl (pH8.5), 50 mM KCl, 1.5 m M MgCl 2 ] , 1 µL of 10 mM dNTP mixture, 1 µL of Taq polymerase (2.5 U), 1 µL of bacterial DNA extract as template, and 2 µM of primer mixture in a PCR tube with a final 50 µL volume. Each PCR product was purified and subjected to (ABI 3730 DNA Analyzer; Applied Biosystems, USA).
The flaA-RFLP The flagellin gene typing was performed according to the method of Nachamkin et al. [19] in order for comparison of virulence, antimicrobial resistance, and the genotypic profile of the C. jejuni and C. coli isolates from the dog and human stools.
The amplification reaction was carried out in a DNA thermal cycler using forward primer (5'-GGATTTCGTATTAA-CACAAATGGTGC-3') and reverse primer (5'-CTGTAGTA ATCTTAAACATTTG-3'). PCR was performed in a 50 µL mixture containing 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl A reagent blank contained all components of the reaction mixture except template DNA, for which sterile distilled water was substituted. This step was included in every PCR procedure.
After amplification, 5 µL of the PCR product was electrophoresed on a 12.5% acrylamide gel (Bio-rad Laboratories, USA) in Tris borate-EDTA (TBE) buffer. The gels were stained with 0.5 µg/mL ethidium bromide to determine the presence or absence of the PCR products. The amplicon of flaA gene was digested with the restriction enzyme DdeI for 2 h at 37 o C. The digested fragments were separated and analyzed by electrophoresis. Acrylamide gels were runned at 75 V for 2 h in 1.0 × TBE buffer. Photographs of gels stained with 0.5 µg/mL ethidium bromide were analysed by Fingerprinting Plus software package (ver. 1.2; Bio-Rad Laboratories). A 1.0 kb DNA ladder was used as a molecular marker. indicate the concentration (µg/mL) at which 50% and 90% of isolates tested were susceptible to the antimicrobial, respectively. MIC range indicates the MIC level for C. jejuni isolates at a particular antimicrobial concentration. %R indicates the ratio of resistance strains for the antimicrobial agent. (≥): resistance breaks point (µg/mL) for the antimicrobials. indicate the concentration (µg/mL) at which 50% and 90% of isolates tested were susceptible to the antimicrobial, respectively. MIC range indicates the MIC level for C. coli isolates at a particular antimicrobial concentration. %R indicates the ratio of resistance strains for the antimicrobial agent. (≥); resistance breaks point (µg/mL) for the antimicrobials. The flaA RFLP pattern was analyzed by BioNumeric software (ver. 4.01; Applied Maths, Belgium). Images of gel were normalized by alingment with 1.0 Kb DNA ladder (Takara Bio). Matching and the dendrogram of the fingerprints determined by the unweighted pair group method with averages were performed using the Dice coefficient with 1% tolerance windows. Tables 1 and 2 . None of the C. jejuni and C. coli isolates from humans and dogs was resistant to erythromycin. Antimicrobial resistance to tetracycline was observed in 45%, 21.7%, 25%, and 82.6% of the C. jejuni isolates from household dogs, stray dogs, breeding dogs, and humans, respectively. C. jejuni isolates from humans showed higher resistance to tetracycline than those isolated from dogs (p ≤ 0.01). Tetracycline resistance of C. jejuni from humans showed higher MIC 50 (64 µg/mL) than those isolated from dogs (0.5 µg/mL). More than 60% of C. jejuni from dogs and humans showed resistance to nalidixic acid, enrofloxacin, and ciprofloxacin. Especially, all of the C. jejuni from breeding dogs were resistant to enrofloxacin and ciprofloxacin. Nalidixic acid resistance of C. jejuni from humans and three different raising groups of dogs revealed equal level of MIC (256 µg/mL). Antimicrobial resistance to gentamicin was observed in 20%, 43.5%, and 6.25% of C. jejuni from household dogs, stray dogs and humans, respectively. However, none of the C. jejuni from breading dogs was resistant to gentamicin. Antimicrobial resistance to ampicillin was observed in 10%, 8.7%, 12.5%, and 91.3% of C. jejuni from household dogs, stray dogs, breading dogs, and humans, respectively. C. jejuni from humans showed higher resistance to ampicillin than those isolated from dogs (p ≤ 0.05). Antimicrobial resistance to tetracycline was observed in 66.7% and 75% of C. coli isolates from stray dogs and humans, respectively. However, none of the C. coli from household dogs and breeding dogs was resistant to tetracycline. More than 50% of C. coli from dogs and humans showed resistance to nalidixic acid and enrofloxacin. Enrofloxacin resistant C. coli from dogs had higher MIC 5 0 (16 µg/ mL) than those isolated from humans (0.125 µg/mL). Antimicrobial resistance to ciprofloxacin and gentamicin was observed in 50% and 25% of C. coli from humans, respectively. However, none of C. coli from dogs was resistant to ciprofloxacin and gentamicin. Antimicrobial resistance to ampicillin was observed in 33.5% and all of C. coli from stray dogs and humans, respectively. However, none of C. coli from household dogs and breeding dogs was resistant to ampicillin.
Stastical analysis
Data were analyzed by Student's t tests. Differences were considered significant at p < 0.05. Data are expressed as means ± standard error.
Results
Antimicrobial susceptibility test
According to the antimicrobial susceptibility test, a large number of Campylobacter spp. isolates used in this study showed a multidrug resistance phenotype. A total of 26 antimicrobial resistance pattern was determined (Table 3) . Of 100 Campylobacter spp. isolates, 32 strains (32.0%) were resistant to 5 drugs, 20 strains (20.0%) were resistant to 4 drugs, 17 strains (17.0%) were resistant to 3 drugs and 13 strains (13.0%) were resistant to 2 drugs. Eighty-five percent (85.0%) of the isolates were resistant to two or more kinds of antibiotics (Table 3) . CIP, GM  3  ---3  TE, NA, ENO, CIP  4  -3  -7  TE, NA, ENO, AM  -1  --1  TE, NA, CIP, AM  --1  -1  NA, ENO, CIP, GM  6  ---6  NA, ENO, CIP, AM  1  -4  -5  TE, NA, ENO, CIP, GM  1  ---1  TE, NA, ENO, CIP, AM  2  -27  2  31  TE, NA, ENO, CIP, GM, AM --3  -3  Total  41  9  46  4  100 EM: erythromycin, NA: Nalidixic acid, CIP: ciprofloxacin, ENO: enrofloxacin, AM: ampicillin, TE: tetracycline, GM: gentamicin.
Mutations in QRDR of gyrA gene
The relationship between quinolone resistance and gyrA mutation was confirmed by DNA sequencing of the gyrA gene in Campylobacter. A total of 87 strains of C. jejuni were selected for analysis of DNA sequence mutations in the QRDR in the gyrA gene. The missense mutation of the 86th codon (ACA→ATA; Thr→IIe) was observed in 34 strains (82.9%) of C. jejuni isolated from dogs, and 35 strains (76%) of C. jejuni isolated from humans, respectively. However, amino-acid substitution (Asp→Asn) in the 90th codon was not found in the gyrA sequence. The silent mutations at the codons 78, 81, 110, 117, 118, and 119 were assessed (Tables  4 and 5 ). The results showed that the silent mutation at the codons 81 (26.8%), 119 (19.5%) and 81 (24%), 110 (2.2%), 117 (2.2%), 119 (4.3%) in the QRDR of the gyrA genes in C. jejuni were isolated from dogs and humans respectively. Also sequencing analysis showed that 100% of NA R and CIP R C. jejuni isolates (n = 63) from dogs and humans have the mutation Thr-86 t h -Ile, which is known to be associated with quinolone resistance, and the mutations were not exhibited in all fluorquinolone-susceptible C. jejuni at the 86th codon (Table 5) .
flaA -RFLP analysis Ninety-four strains of Campylobacter spp. were selected at random for the analysis of flaA-RFLP after digestion with DdeI restriction enzyme to compare phenotype and genotype of the Campylobacter isolates from dogs and humans (Fig.  1) . The fla-RFLP typing distributed 73 strains of C. jejuni and C. coli into 12 major fla-RFLP clusters. Twenty one strains of C. jejuni and coli were not included in major cluster (Fig. 2) , because they had low similarity (lower than 90% similarity). The frequently detected patterns of the fla-RFLP cluster were cluster 1 (n = 12) of C. jejuni and cluster 5, 6, 7 of C. coli isolates (Fig. 2) . Eight fla-RFLP clusters of 1, 2, 3, 5, 8, 10, 11, and 12 included C. jejuni and C. coli from human. Other 8 fla-RFLP clusters of 1, 2, 3, 4, 5, 6, 7, and 9 included C. jejuni and C. coli isolated from dogs. The clusters of 8, 10, and 12 have only human isolates and clusters of 4, 6, 7, and 9 were assigned only to dog isolates (Fig. 2) . Clusters of 1, 2, 3, 5, and 11 included C. jejuni and C. coli isolated from dogs and humans simultaneously and the genotype and the phenotype were compared in these clusters (Fig.  3) . No strain with a complete homogenous genotype and phenotype was detected.
Discussion
A tendency of increase of antimicrobial resistance in Campylobacter spp. can be recognized as a major public health concern [7, 23] . In this study, the prevalence of antimicrobial resistance in Campylobacter spp. isolated from dogs raised in diverse conditions and humans was investigated, and the relationship between fluoroquinolon resistance and the gyrA mutation was revealed. In this study, no erythromycin resistant Campylobacter spp. isolates from dogs and humans was identified. This result agrees with the previous studies which suggested that none of C. jejuni isolates from humans and companion animals was resistant [16, 28] . However, other studies reported 3-6.8% of erythromycin resistance in C. jejuni isolated from humans [7, 18] .
Resistance to ampicillin and other β-lactam antimicrobials has been broadly studied by previous reports [20, 28] . C. jejuni resistance to ampicillin is known to be correlated with production of ß-lactamase. The β-lactamase is produced by cj0299 open reading frame which is located on a chromosomal DNA in Campylobacter spp. [21] . The resistance to ampicillin we observed in C. jejuni was 8.7-12.5% from dog isolates and 91.3% from human isolates. In C. coli, a lower level of resistance was observed in the isolates from dogs. Frequency of ampicillin resistance of C. jejuni from dogs and humans in this study are similar with the previous reports [1, 32] . C. jejuni isolates from humans showed higher resistance to ampicillin than those isolated from dogs (p ≤ 0.05). However, C. jejuni isolates from three different raising groups of dogs were not statistically significant.
The rates of tetracycline resistance were previously reported, ranging from 13 to 78.8% among the Campylobacter spp. isolates from humans and companion animals [16, 18, 30] . A higher rate of resistance to tetracycline was also observed, mainly in C. coli isolated from pigs and broilers (62 and 52%, respectively) [30] . In this study, the resistance of C. jejuni to tetracycline ranged from 21.7~40% in dog isolates and 83.3% in human isolates. C. jejuni isolates from humans showed a higher resistance to tetracycline than those isolated from dogs (p ≤ 0.01). However, C. jejuni isolates from three different raising groups of dogs were not statistically significant. Since tetracycline has been used as an alternative treatment for Campylobacter gastroenteritis, the tetracycline resistance in the isolates of humans has been increasing [18, 20] , moreover, the usage of tetracyclines is increasing due to inexpensive cost and their broad spectrum of activity.
Fluoroquinolone resistance is mostly shown in the human isolates of both C. jejuni and C. coli [25] . Among C. jejuni isolates from dogs, the rates of resistance were 75~90% for nalidixic acid, 56.5~100% for enrofloxacin and 60~100% for ciprofloxacin. In the results of antimicrobial susceptibility test for Campylobacter spp. isolates from humans for quinolones, the rates of resistance were 87% for nalidixic acid, 80.4% for enrofloxacin, and 80% for ciprofloxacin. The fluoroquinolone resistance of C. jejuni from humans and dogs in this study was similar with previous reports [3, 15, 29] . The results of C. coli isolates from humans were 50% resistant to three fluoroquinolones. Among C. coli isolates from dogs, the rates of resistance were 50~66.7% for nalidixic acid and 100% for enrofloxacin. However, all strains of C. coli isolated from dogs were susceptible to ciprofloxacin. Globally, antimicrobial resistance rate of C. coli isolates from humans and dogs raised in diverse condition did not show significant stastical difference because of a small number of isolates used in this study. Many previous studies showed that the Thr-86 t h -Ile (ACA→ATA) mutation in the QRDR of gyrA is the most common mechanism causing nalidixic acid or ciprofloxacin resistance in C. jejuni [11] . Piddock et al. [22] had demonstrated that a Thr-86 t h to Ile change is present in the huge majority of fluoroquinolone resistant Campylobacter spp., whether isolated from dogs or humans. The association of this substitution with quinolone resistance in Campylobacter spp. has been reported previously [6] .
Regarding the gyrA mutation in the QRDR, it was found that all the fluoroquinolone resistant isolates (n = 63) possessed the mutation at the 86th codon (threonine to isoleucine) of the gyrA gene originated from Campylobacter spp. isolates used in this study. In the case of silent mutation, the mutations were found at the codons 81 (CAC→CAT), 110 (GGC→GGT), 117 (GGT→GGC), 119 (AGC→AGT), which is in line with the previous reports [33] and sequencing analysis showed that 100% of NA R / CIP R C. jejuni isolates from dogs and humans had the mutation Thr-86 t h -Ile, which is known to be associated with quinolone resistance.
The flaA-PCR-RFLP has been applied as one of the tools of epidemiological study to differentiate isolates below the species level [10, 13] . Accordingly, flaA-RFLP typing method was used to analyze the genotype. Ninety four strains of Campylobacter isolates were subtyped by flaA-PCR-RFLP into 12 major clusters. Interestingly, clusters of 1, 2, 3, 5, and 11 included dog and human isolates simultaneously. These results suggest epidemiological co-relationship between C. jejuni isolated from dogs and humans. However, these results may not simply imply that there is no relationship between the Campylobacter spp. isolated from dogs and humans, because these strains were not isolated from homogenous environment at the same time. For further study, molecular epidemiological comparison of Campylobacter spp. isolated from pet owners and their dogs would be necessary.
